EYES Historical PE Ratio image   This EYES PE ratio history page last updated 8/16/2022
EYES PE History Chart
PeriodPriceEarningsTTMPE
Q1 2022
5/16/2022
1.48-0.06-0.14NA
Q4 2021
3/29/2022
1.48-0.02-0.08NA
Q3 2021
11/12/2021
2.72-0.06-0.14NA
Q2 2021
8/13/2021
3.64-0.08-0.26NA
Q1 2021
5/13/2021
5.14-0.12-0.40NA
Q4 2020
3/16/2021
13.20-0.06-0.85NA
Q3 2020
11/12/2020
0.80-0.07-1.26NA
Q2 2020
8/13/2020
0.90-0.15-1.67NA
Q1 2020
6/29/2020
0.98-0.57-2.00NA
Q4 2019
3/19/2020
2.88-0.47-1.99NA
Q3 2019
11/14/2019
6.95-0.48-2.32NA
Q2 2019
8/6/2019
6.27-0.48-2.72NA
Q1 2019
5/15/2019
7.70-0.56-3.12NA
Q4 2018
3/13/2019
6.73-0.80-3.68NA
Q3 2018
11/7/2018
13.60-0.88-4.00NA
Q2 2018
8/7/2018
13.36-0.88-4.00NA
Q1 2018
5/10/2018
15.44-1.12-4.08NA
Q4 2017
3/7/2018
14.80-1.12-4.24NA
Q3 2017
11/2/2017
9.28-0.88-4.48NA
Q2 2017
8/1/2017
9.68-0.96-4.80NA
Q1 2017
5/3/2017
10.16-1.28-5.20NA
Q4 2016
3/9/2017
12.40-1.36-4.96NA
Q3 2016
11/2/2016
18.40-1.20-4.64NA
Q2 2016
7/28/2016
32.96-1.36-4.24NA
Q1 2016
4/28/2016
40.48-1.04-3.84NA
Q4 2015
3/3/2016
41.36-1.04-3.76NA
Q3 2015
10/29/2015
50.00-0.80-4.08NA
Q2 2015
8/4/2015
113.20-0.96NANA
Q1 2015
5/13/2015
93.04-0.96NANA
Q4 2014
3/11/2015
127.68-1.36NANA
EYES Historical PE Ratio Chart
PeriodPriceEarningsAnnualizedPE
Q1 2022
5/16/2022
1.48-0.06-0.24NA
Q4 2021
3/29/2022
1.48-0.02-0.08NA
Q3 2021
11/12/2021
2.72-0.06-0.24NA
Q2 2021
8/13/2021
3.64-0.08-0.32NA
Q1 2021
5/13/2021
5.14-0.12-0.48NA
Q4 2020
3/16/2021
13.20-0.06-0.24NA
Q3 2020
11/12/2020
0.80-0.07-0.28NA
Q2 2020
8/13/2020
0.90-0.15-0.60NA
Q1 2020
6/29/2020
0.98-0.57-2.28NA
Q4 2019
3/19/2020
2.88-0.47-1.88NA
Q3 2019
11/14/2019
6.95-0.48-1.92NA
Q2 2019
8/6/2019
6.27-0.48-1.92NA
Q1 2019
5/15/2019
7.70-0.56-2.24NA
Q4 2018
3/13/2019
6.73-0.80-3.20NA
Q3 2018
11/7/2018
13.60-0.88-3.52NA
Q2 2018
8/7/2018
13.36-0.88-3.52NA
Q1 2018
5/10/2018
15.44-1.12-4.48NA
Q4 2017
3/7/2018
14.80-1.12-4.48NA
Q3 2017
11/2/2017
9.28-0.88-3.52NA
Q2 2017
8/1/2017
9.68-0.96-3.84NA
Q1 2017
5/3/2017
10.16-1.28-5.12NA
Q4 2016
3/9/2017
12.40-1.36-5.44NA
Q3 2016
11/2/2016
18.40-1.20-4.80NA
Q2 2016
7/28/2016
32.96-1.36-5.44NA
Q1 2016
4/28/2016
40.48-1.04-4.16NA
Q4 2015
3/3/2016
41.36-1.04-4.16NA
Q3 2015
10/29/2015
50.00-0.80-3.20NA
Q2 2015
8/4/2015
113.20-0.96-3.84NA
Q1 2015
5/13/2015
93.04-0.96-3.84NA
Q4 2014
3/11/2015
127.68-1.36-5.44NA
Quotes delayed 20 minutes

Email EnvelopeFree EYES Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Second Sight Medical (EYES) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

EYPT PE Ratio History
FATE PE Ratio History
FBIO PE Ratio History
FBRX PE Ratio History
FDMT PE Ratio History
FEMY PE Ratio History
FGEN PE Ratio History
FHTX PE Ratio History
FIXX PE Ratio History
FLDM PE Ratio History
On this page we presented the EYES PE Ratio History information for Second Sight Medical' stock. The average EYES PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average EYES PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this EYES PE ratio history result, against the recent PE: when this page was posted on 8/15/2022, the most recent closing price for EYES had been 2.01, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on EYES or any other given stock, valuation analysis for EYES can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Second Sight Medical PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for EYES. Thanks for visiting, and the next time you need to research EYES PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: THMAU Historical Stock Prices, IBCP Price Target, Best Dividend Paying Stocks Analysts Like.

 

EYES PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.